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ABSTRACT
The combination of RNA interference (RNAi) with the
tetracycline-controlled transcription activation (tet)
system promises to become a powerful method for
conditional gene inactivation in cultured cells and in
whole organisms. Here, we tested critical sequence
elements that originated from miRNA mR-30 for
optimal efficiency of RNAi-based gene knockdown
in mammalian cells. Rationally designed miRNAs,
expressed conditionally via the tet system, led to
an efficient knockdown of the expression of both
reporter genes and the endogenous mitotic spindle
protein TPX2 in HeLa cells. Quantitative studies of
the tet-controlled gene inactivation revealed that
the residual expression of the target gene is an in-
trinsic attribute of all cells that cannot be eliminated
either by increasing the miRNA to target mRNA ratio
or by simultaneous expression of miRNAs targeting
different sequences within the transcript. The
kinetic analysis of the reversibility of the miRNA
mediated knockdown suggests that the recovery
of target gene expression is primarily driven by cell
division. Our miRNA design provides a useful tool
for conditional gene inactivation in combination
with the RNA-polymerase II based tet system. The
identified characteristics of the conditional
RNAi-mediated knockdown need to be considered
for its application in cell culture or in vivo.
INTRODUCTION
Despite deciphering the complete sequence information of
more than 2300 eukaryotic genomes (Entrez Genome
Project), determining gene functions within living organ-
isms remains challenging. The discovery of RNA interfer-
ence (RNAi) (1) in the nematode Caenorhabditis elegans
provided a simple but speciﬁc tool for down-regulation
(knockdown) of gene expression. As such, it was applied
inthefunctionalanalysisofgenesfromacompletechromo-
some (2) or the entire genome (3,4) of C. elegans. More
recently, the use of the RNAi technology was expanded
to mammalian cells, initially through transient transfection
of siRNAs (5) and later on through stable expression of
shRNAs from RNA polymerase III (polIII) promoters (6).
To link a gene sequence to its function in a living
organism, one method of choice is the combination of
the RNAi technology with a conditional gene expression
system that as a result provides spatial and temporal
control over the gene function. The tetracycline-controlled
transcription activation system (tet system) (7) is the most
widely used tool for conditional, yet fully reversible regu-
lation of gene expression. Tet-regulated shRNA expres-
sion was used successfully for temporal gene knockdown
in cell culture (8,9). However, these systems are not
suitable for cell-type speciﬁc gene inactivation since they
rely on a repression principle. The most promising
approaches applicable for the use in living organisms
consist of either the expression of a shRNA under an ac-
tivator dependent, tet-regulated pol III system (10) or the
expression of a redesigned microRNA (miRNA) under
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promoter of the original tet system (Ptet–1) (11,12).
Endogenous miRNAs are small, non-coding RNAs ex-
pressed in most tissues and involved in many developmen-
tal processes (13). They are typically transcribed by pol II
(14), released as a pre-form from their primary transcripts
by the action of the Drosha–DGCR8 complex (15,16) and
exported from the nucleus to the cytoplasm by Exportin 5
(17). The pre-miRNAs are subsequently processed by
Dicer to generate mature miRNAs (18), these are then
transferred to and processed by the protein Argonaute 2,
the catalytical engine of the ‘RNA-interfering silencing
complex’ (RISC) [reviewed in (19)]. A miRNA equipped
with a double-stranded sequence fully complementary to
the target mRNA will trigger its RISC-dependent degrad-
ation (20). Such a miRNA driven by a pol II promoter is a
suitable tool for inducing RNAi-mediated gene inactiva-
tion in vivo.
The knockdown of gene expression by miRNA-
mediated RNAi expressed under the control of the tet
system promises to become a versatile method for tissue
speciﬁc, conditional inhibition of selected gene activity in
cell culture as well as in living organisms. Additionally,
this approach allows the exploitation of the large reper-
toire of already existing mouse lines expressing the tetra-
cycline activator (tTA or rtTA) in a cell-type speciﬁc
manner (21).
In this study, we describe a design of minimized miRNA
applicable for the knockdown of any gene of interest via
the tet system. Within the rationally designed miRNAs,
the functions of the individual sequence elements are sys-
tematically characterized. The most potent miRNAs in
combination with pol II promoters match the efﬁcacy of
knockdown achieved by a pol III driven shRNA. We also
provide a detailed description of the dynamic range of
gene regulation that is possible with tet-regulated
miRNAs. The rational basis for the application of this
technology is prepared by the quantitative kinetic
analysis of the miRNA mediated gene knockdown and
the reinduction of the expression of targeted mRNA
after termination of miRNA expression.
MATERIAL AND METHODS
Generation of plasmid vectors
All miRNAs described herein were generated from
two end-to-end matching oligonucleotide primers
(Supplementary Table S1; biomers.net, Germany) by PCR
using Pwo-polymerase (Roche, Germany). Resulting
DNAs, coding for the respective miRNA targeting either
ﬁreﬂy (ﬂuc) or renilla luciferase (rluc), were subsequently
cloned into pSKII+ mod2 (Supplementary Data) as
EcoRI/PstI fragments. This yielded respective pSKII+
mod2 vectors containing a single miRNA. For the con-
struction of plasmids, in which miRNAs are under the
control of either the CMV promoter (PCMV) or the
tet-regulatable promoter (Ptet–1), respective miRNA-
coding DNA was released from the pSKII+ mod2
vector by EcoRI and XbaI and the resulting fragment
was cloned into either pUHD 10-1 [PCMV; (22)] or
pUHD10-3 [Ptet–1; (23)]. For the generation of vectors,
in which the miRNA is expressed under the control of
the promoter of the RNA component of RNase P,
H1 (PH1), the respective miRNA-coding DNA fragment
was excised from the pSKII+mod2 vector using BglII and
XhoI and cloned into pSUPER (6).
All shRNAs described herein (Supplementary Table S1)
were generated by the annealing of two complementary
oligonucleotides (biomers.net, Germany), designed as
described in the guidelines of Brummelkamp et al. (6).
For vectors, in which a respective shRNA is expressed
under the control of PH1, annealed oligonucleotides
forming shRNA(FL-B) or shRNA(RL-A) were integrated
into pSUPER by the use of the restriction sites BglII and
HindIII. For the generation of vectors, in which the re-
spective shRNA is expressed under control of PCMV, the
corresponding oligonucleotides (Supplementary Table S1)
were annealed and cloned into pUHD10-1 via EcoRI
and XbaI.
The vector pBI-11 miRNA3(FL-B), in which the bidir-
ectional tet-regulated promoter (Ptet bi–1) (24) controls the
expression of miRNA3(FL-B) and rluc, was generated in a
two-step process. First, miRNA3(FL-B) was released as a
fragment having a blunt EcoRI and a NheI site from its
pSKII+mod2 vector and then cloned into pBI-4 (24) cut
with PvuII and NheI yielding pBI-4 miRNA3(FL-B).
Next, the reading frame of rluc, released from
pRL-SV40 (Promega, Germany) as a fragment with a
blunt SacI and a SalI site, was ligated with a vector
fragment from pBI4 miRNA3(FL-B) with a blunt NotI
site and a SalI site, yielding pBI-11 miRNA3(FL-B).
Plasmid pBI-9 miRNA3(TPX2-C), in which Ptet bi–1
controls the expression of eGFP and miRNA3(TPX2-C)
was constructed by integrating the PCR-synthesized DNA
of this miRNA3 (Supplementary Table S1), digested with
PvuII and NheI, into pBI-eGFP (Clontech, USA). In a
subsequent step, the tet-regulated bidirectional expression
cassette was released from pBI-9 miRNA3(TPX2-C) by
HpaI and BglII and cloned into pBI-F3.M.F (25)
cut with the same restriction sites. The resulting plasmid
[pBI-9F.miRNA3(TPX2-C)] enables Flp-mediated
recombinase-mediated cassette exchange (RMCE) of the
tet-regulated expression cassette in a well deﬁned locus of
cell line HeLa EM2-11 (25) with optimal regulatory
properties.
The construction of the vectors, in which a ﬂuc fusion
protein is expressed under the control of either PCMV
[pUHD(NR1_opt3)-131-1] or the promoter of elongation
factor 1a (PEF1a) [pUHD(NR1_opt3)-131-EF1a], is
described in the Supplementary Data.
Cell culture and transient transfections
Wild-type HeLa cells (CCL-2, American Type Culture
Collection, USA) and all derived HeLa cell lines were
cultured in DMEM-medium (Invitrogen, Germany) sup-
plemented with 10% tet-approved FCS (Clontech, USA)
at 37 C and 5% CO2. For transient expression experi-
ments, 15–20mg of a respective DNA mixture was added
to 2–3 million cells in 300ml serum free DMEM medium in
a 4-mm GenePulser cuvette (BioRad). The cells were
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(BTX, USA) at 200V, 25 and 975mF at room tempera-
ture and spread on adhesion-enhanced six-well tissue
cultures plates (Cell+, Sarstedt, Germany). The DNA
mixture consisted of equal amounts of a vector for con-
stitutive ﬂuc production (pCMV-luc; D. Bartsch, unpub-
lished data), a vector for constitutive expression of the rluc
gene (pRL-SV40; Promega, Germany) and the vector that
expresses the respective interfering RNA from either PCMV
or PH1. For the transient expression of tet-regulated
miRNAs equal amounts of plasmids pCMV-luc,
pRL-SV40, pUHT61-1 and the respective miRNA vector
were used. pUHT61-1 is a plasmid, in which the gene of
the optimized tTA2 is expressed by PCMV (26). For the
experiments, in which the expression of both ﬂuc and
rluc was inactivated by simultaneous production of re-
spective miRNAs, a proportionate amount of vector
pUHD34-1, having the gene for eGFP under the control
of PCMV, was added in addition to the above described
DNA mixture.
After 36h of growth in regular or doxycycline (dox)
(Sigma, Germany) containing medium, the cells were
washed twice with PBS and lysed on tissue culture plate
surface with passive lysis buffer (Promega, Germany).
From the lysates, following centrifugation at 14000rpm
for 5min at 4 C, the ﬂuc and rluc activities were measured
in the supernatant using the Dual-Luciferase Reporter
Assay system (Promega, Germany) according to the
manufacturer’s recommendations in combination with
Wallac Victor 2 multilabel counter (PerkinElmer, USA).
Relative activity of ﬂuc was obtained by normalization of
ﬂuc activity to rluc; relative rluc activity was normalized to
ﬂuc activity. In the case of the experiments that
demonstrated simultaneous knockdown of ﬂuc and rluc
by co-expression of both miRNAs, eGFP ﬂuorescence
was determined in the lysate using the Wallac Victor 2
multilabel counter and used for normalization of transfec-
tion efﬁciency.
Generation of stably transfected cell lines
HtTA 15-1, HtTA 16-1 and HtTA 16-2 triple stable cells
were obtained by transfecting the cell lines HtTA 15 and
HtTA 16 (generation described in Supplementary Data)
with 20mg SapI-linearized pBI-11 miRNA3(FL-B) and
2mg EcoRI-linearized pPUR (Clontech, USA) via electro-
poration as described above. One day after transfection,
the cells were treated with G418 (200mg/ml), hygromycin
(200mg/ml) and puromycin (2mg/ml) for selection of re-
spective transgenic expression cassettes and 100ng/ml dox
to keep tet-regulated expression turned off. For clonal
analysis, cells were washed twice with PBS and then
cultivated in dox-free medium for 3days. Cell lysis and
determination of ﬂuc and rluc activities was carried out
as described above. The protein concentration of the
sample, used for normalization of luciferase activities,
was determined using the BioRad Protein assay according
to the manufacturer’s protocol.
For the stable cell line with rtTA-inducible miRNA
mediated TPX2 knockdown, the plasmid pBI-9F
miRNA3(TPX2-C) was used for stable integration into
cell line HeLa EM2-11ht via recombinase-mediated
cassette exchange (RMCE) as described in Weidenfeld
et al. (25). The HeLa EM2-11-TPX2 cells were grown to
25% conﬂuence and the addition of 200ng/ml dox was
used to induce expression of miRNA3(TPX2-C) and
eGFP at time point 0. Samples were taken at desired
time points and either ﬁxed with 3% paraformaldehyde
for immunoﬂuorescence analysis, 70% Ethanol for ﬂow
cytometry or directly resuspended in SDS sample buffer
for quantitative western blot analysis.
Quantiﬁcation of mRNA concentrations by
real-time RT–PCR
Total RNA of the respective cells was isolated using
TRIzol Reagent (Invitrogen, Germany) according to the
manufacturer’s recommendations. To remove any traces
of contaminating genomic or plasmid DNA, the RNA was
reconstituted in RNase-free water and incubated with
50U RNase-free DNase I (Roche, Germany) under rec-
ommended conditions for 15min at 37 C. To terminate
DNase I digestion, 500ml TRIzol was added to the
reaction mixture. Subsequent RNA extraction followed
according to the manufacturer’s protocol.
Next, 1mg of total RNA was used for reverse transcrip-
tion with SuperScript III and oligo(dT)20 primer
(Invitrogen, Germany) according to manufacturer’s
protocol. Resulting cDNAs were diluted 1/2 and 1/4 and
1ml of either undiluted or respectively diluted cDNA sub-
jected to real-time PCR analysis as duplicates.
Real-time PCR reactions were run on an Applied
Biosystems 7900 HT fast real-time PCR system. For sim-
ultaneous detection of ﬂuc and rluc mRNA, the following
primers and probes were used: ﬂuc forward primer 50-TGT
GGACGAAGTACCGAAAGGT-30; ﬂuc reverse primer
50-CTTCTTGGCCTTTATGAGGATCTC-30; ﬂuc probe
50-FAM-CCGGAAAACTC-GACGCAAGAAAAATCA
G-TAMRA-30; rluc forward primer 50-AAAGGTGAAG
TTCGT-CGTCCA-30; rluc reverse primer 50-CAACGTC
AGGTTTACCACCTTTT-30; rluc probe 50-HEX-CATT
ATCATGGCCTCGTGAAATCCCGT-TAMRA-30 (FAM:
6-carboxy-ﬂuoresceine; HEX: hexachloro-ﬂuoresceine;
TAMRA: 6-carboxy-tetramethyl-rhodamine; biomers
.net). Real-time PCR was performed in a total volume
of 20ml using the Taqman Universal PCR master mix
(Applied Biosystems, Germany) according to the manu-
facturer’s protocol. Final concentrations of primers were
300nM, those of probes 250nM. For detection of human
b-actin, we used the following primers: Actin forward
primer: 50-AGCAC-AGAGCCTCGCCTTT-30; Actin
reverse primer: 50-AGGGTGAGGATGCCTTCTCTT-30.
In this case, real-time PCR was conducted with the Power
SYBR-Green PCR master mix (Applied Biosystems,
Germany) according to the manufacturer’s guidelines.
Final concentrations of primers were 300nM.
Quantiﬁcation of mature miRNA
Detection of processed miRNA was performed using a
Custom Taqman Small RNA Assay (AssayID:
CCN0QSF, Applied Biosystems, Germany) according to
the manufacturer’s protocol. Brieﬂy, 10ng of total RNA
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with 7ml of recommended RT-master mix (containing
Superscript III reverse transcriptase) and 3ml of the
5 RT primer provided with the Taqman Small RNA
Assay. RT reaction was run in a thermocycler,
programmed for 30min at 16 C, 30min at 42 C and
5min at 80 C. Real-time PCR reactions were run with
either undiluted, 1/2 or 1/4 diluted RT reactions using a
Applied Biosystems 7900 HT fast real-time PCR system in
accordance with the recommended protocol. Each PCR
reaction was performed in triplicates and consisted of
1ml RT reaction, 1ml Custom Taqman Small RNA
Assay and 10ml Taqman Universal PCR Master Mix
(Applied Biosystems, Germany) in a total volume of 20ml.
Immunoﬂuorescence, immunoblotting and ﬂow cytometry
Immunoﬂuorescent detection was performed using poly-
clonal antibodies against full length human TPX2 (27), or
GFP (a kind gift from Dirk Go ¨ rlich) or a monoclonal
antibody against a-Tubulin (Sigma, DM1a). To quantify
nuclear TPX2 signals, cells were imaged and TPX2 ﬂuor-
escence was determined over background signal using the
Image J software. Flow cytometry was performed as
described (28). Western blot analysis was performed as
described (29) using a LICOR infrared scanning system
and the corresponding software.
Tumour growth analysis with the nude mouse
xenograft model
Female nude mice (Crl:CD1-Foxn1
nu) were obtained from
Charles River (Sulzfeld, Germany) at an age of 6–8weeks.
They were housed at speciﬁc pathogen-free conditions in a
mini barrier system of the central animal facility of the
German Cancer Research Center and kept under
controlled conditions (21±2 C room temperature, 60%
humidity, and 12-h Light–dark rhythm). Autoclaved food
and water were given ad libitum to the animals.
Experiments were approved by the responsible govern-
mental animal ethics committee (Regierungspra ¨ sidium
Karlsruhe, Germany). Sub-conﬂuent cells of the line
HeLa EM2-11- mCherry (Kai Scho ¨ nig and Dusan
Bartsch, unpublished) or HeLa EM2-11-TPX2 were har-
vested using 2mM EDTA in PBS (phosphate buffered
saline without Ca
2+ and Mg
2+), counted in a Neubauer’s
chamber and suspended in RPMI 1640-medium in the re-
spective dilution. An amount of 75ml of the medium con-
taining either 10
4 or 10
5 cells was augmented with 25ml
Geltrex (Invitrogen, Germany) and subsequently injected
subcutaneously along the mammary line of the nude mice.
The horizontal and vertical diameter of the tumour was
determined using external calipers and the volume
calculated according to a
2 b/2 (a b).
RESULTS
Gene inactivation efﬁciencies of miRNAs expressed
under control of RNA polymerase II or III promoters
To identify the miRNA core sequences necessary for efﬁ-
cient gene knockdown, we tested three different miRNA
designs (Figure 1A). The central block of all miRNAs was
a double-stranded sequence of 21nt completely homolo-
gous to the targeted mRNA (boxed sequences in
Figure 1A). In miRNA1 this central double-stranded
region was ﬂanked by sequences necessary for Dicer
cleavage (30), which were derived from endogenous
miRNA mR-30. In miRNA2, additional sequences con-
taining the Drosha cleavage site and the nuclear export
signal of mR-30 (15) were added to the 50-end and the
30-end of the miRNA1, respectively. In miRNA3, the
loop connecting the sense and the antisense targeting
sequence was exchanged for an improved version origin-
ally described by Boden et al. (31).
For the functional and quantitative evaluation of the
different miRNA designs, a 21-bp ﬁreﬂy luciferase (ﬂuc)
target sequence (FL-B) was included, which has been pre-
viously shown to confer efﬁcient ﬂuc knockdown (32). The
respective miRNAs were cloned into vectors, in which
their expression was controlled either by the pol III de-
pendent promoter of the RNA component of RNase P,
H1 (PH1), or by the pol II dependent human cytomegalo-
virus immediate early promoter (PCMV). For reference, a
shRNA sharing the same ﬂuc targeting sequence was con-
structed according to Brummelkamp et al. (6) and cloned
into both pol II and pol III expression vectors.
The knockdown efﬁcacy of the different miRNA
designs was evaluated in transient expression experiments,
in which the particular expression vector for each miRNA
was transfected into HeLa cells together with vectors con-
stitutively expressing ﬂuc (targeted mRNA) and renilla
luciferase (rluc), the latter serving as an internal
standard for transfection efﬁciency. The mRNA concen-
trations and the enzymatic activities of both ﬂuc and rluc
were quantiﬁed from total RNA and protein lysates
yielded from transfected cells. In addition, the concentra-
tion of mature miRNA yielded from each individual
miRNA design was determined.
The comparison of efﬁcacy between PH1 expressed
shRNA and miRNAs is shown in Figure 1B–D. The
best reduction of ﬂuc activity was achieved by the conven-
tional shRNA (residual ﬂuc activity of 3%), although sig-
niﬁcant knockdown efﬁciencies were also obtained with
miRNA2(FL-B) (residual ﬂuc activity 15%) and
miRNA3 (residual ﬂuc activity 10%) (Figure 1B). The
least efﬁcient downregulation of ﬂuc activity in this experi-
ment was observed upon transfection with
miRNA1(FL-B) (residual ﬂuc activity 30%), indicating
that sequences for Drosha cleavage and nuclear export
in miRNA2 and miRNA3 contribute to some degree to
the knockdown potency of pol III produced miRNAs. The
knockdown efﬁciency measured by luciferase activities
were also reﬂected by the relative ﬂuc mRNA concentra-
tions, although relative residual mRNA concentrations
were higher (Figure 1C). The higher cellular concentration
of mature miRNA generated from miRNA2 and miRNA3
compared to miRNA1 (Figure 1D) supports again the
beneﬁcial effect of Drosha cleavage and nuclear export
sequences on miRNA processing.
When the inhibitory RNAs were expressed from a pol II
dependent promoter, no impediment of ﬂuc activity was
observed with either shRNA(FL-B) or miRNA1(FL-B)
e168 Nucleic Acids Research, 2010,Vol.38, No. 17 PAGE 4 OF 17Figure 1. Knockdown efﬁciencies of different miRNA designs. (A) Sequences and secondary structures of different miRNA designs. Boxed sequences
are the double-stranded RNA sequences matching the target site within the ﬁreﬂy luciferase (ﬂuc) mRNA. Added or modiﬁed sequence elements
from miRNA1 to miRNA3 are explicitly labelled. Dicer: Dicer cleavage sequences (30). Drosha/Exportin 5: Sequences for cleavage by Drosha and
nuclear export signal by Exportin 5 (15). Dicer 2: Dicer cleavage loop as used in miB-tat in Boden et al. (31). (B–G) Quantiﬁcation of knockdown
efﬁciencies of differently designed miRNAs, expressed from either the pol III promoter PH1 (B–D) or the pol II promoter PCMV (E–G). Relative ﬂuc
activities (B and E), relative ﬂuc mRNA concentrations (C and F) and the concentrations of mature miRNA (D and G) were determined in cell
extracts from individual transient expression experiments. The results in B and E were normalized to activity and in C and F to mRNA concen-
tration of rluc, produced from the SV40 promoter within the co-transfected expression vector. Figures B–G show the means and SEM from multiple
samples of at least two independent transfection experiments. (A)n1: SV40 polyadenylation signal. TTTTT: pol III termination signal.
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in miRNA2 and miRNA3, increased knockdown
efﬁciencies by 10- to 20-fold [miRNA2(FL-B), residual
ﬂuc activity 13%; miRNA3(FL-B), residual ﬂuc activity
6%]. The relative ﬂuc mRNA concentrations upon trans-
fection also reﬂect the ﬂuc activity measurements,
although the relative residual mRNA concentrations
were again much higher than the relative residual
luciferase activity (Figure 1F). The concentration of
mature miRNAs in transfected cells (Figure 1G) was
highest with miRNA2(FL-B) and miRNA3(FL-B),
demonstrating the importance of Drosha and nuclear
export sequences for the efﬁcacy of pol II driven miRNAs.
The concentration of mature miRNA2(FL-B) and
miRNA3(FL-B) produced by pol II is superior to that
yielded by miRNAs expressed from the very strong
pol III promoter PH1. Correspondingly, the resulting
knockdown of ﬂuc activity is most efﬁcient by pol II
driven miRNA2(FL-B) and miRNA3(FL-B), with an
efﬁcacy comparable to the pol III expressed shRNA.
Interestingly, all knockdown efﬁciencies determined by
mRNA quantiﬁcation are lower than the efﬁciencies
determined by measuring reporter gene activity.
General applicability of the most efﬁcient miRNA design
Next, we tested whether the high efﬁcacy observed with
miRNA2 and miRNA3 produced by pol II is applicable
for other mRNAs than ﬂuc. Therefore, we tested a 21-bp
sequence (RL-A) targeting renilla luciferase (rluc), with no
homology to ﬂuc site FL-B, in the context of all three
miRNA designs. As seen in Supplementary Figure S1,
the relative knockdown efﬁciencies achieved with the re-
spective shRNA and miRNAs targeting rluc at sequence
RL-A are comparable with those targeting ﬂuc at
sequence FL-B (Figure 1B and E), providing evidence
for the general applicability of the identiﬁed designs.
Although we did not observe a signiﬁcantly higher
knockdown efﬁciency with miRNA3 compared to
miRNA2, we still think that the improved loop may
provide efﬁcient Dicer processing for a wider range of
target sequences. For this reason, we have selected
miRNA3 as the design of choice for further experiments.
In the next experiment, we investigated whether the
minimized miRNA3 sustains its high knockdown efﬁcacy
independently of its surrounding sequences within the pol
II generated transcript. We therefore cloned
miRNA1(FL-B) and miRNA3(FL-B) into the expression
vector pIntron (Supplementary Figure S2A). In these
plasmids, the respective miRNA is located within an arti-
ﬁcial intron that precedes the ORF of eGFP. The expres-
sion of the entire mRNA, including the intron, is
controlled by PCMV. The knockdown efﬁcacies of the
intronic miRNAs were compared in transient transfection
experiments with efﬁcacies of the same miRNAs cloned
into the pCMV vector used in previous experiments. Our
results show that knockdownefﬁcacy ofmiRNA3(FL-B) is
independent of the expression vector used (Supplementary
Figure S2B). Therefore, we conclude that the miRNA3 can
operate as a functional unit independent from the integra-
tion sequences in the expression vector.
In an alternative RNAi-capable miRNA, used within
the BLOCK-iT pol II miR RNAi expression system
(Invitrogen, USA), the antisense sequence of the mRNA
target site is present on the 50-side and the corresponding
sense sequence on the 30-side of the Dicer cleavage loop,
which is the opposite orientation of the sequences
compared to our miRNA designs. To clarify the inﬂuence
of sense and antisense sequence orientation within
the miRNA on gene knockdown efﬁciency, we generated
miRNA3-rev(FL-B), in which the 21nt antisense sequence
of the target site is placed 50- and the 21-nt sense sequence
30 of the Dicer cleavage loop, similar to the BLOCK-iT
design. In a transient transfection experiment, both the
miRNA3-rev(FL-B) and miRNA3(FL-B), produced
from PCMV, had identical efﬁcacy. The residual ﬂuc
activity upon transfection of miRNA3-rev(FL-B) was
8.4±1.1% and upon transfection of miRNA3(FL-B)
was 6.1±0.5%.
Efﬁcacy of gene inactivation in stable cell lines with
tet-regulated miRNA expression
As the miRNA3 design was most effective in transient
transfection experiments, we established stably transfected
cell lines with the tet-regulated miRNA3(FL-B) construct
for detailed kinetic analyses of miRNA activity. First, the
genome of the original Tet-Off HeLa cell line HtTA,
bearing a cassette for constitutive expression of tTA (7),
was augmented with a modiﬁed ﬂuc gene, constitutively
expressed from PCMV (33). Two stable cell clones with
both transgenes (HtTA 15 and 16) that showed constitu-
tive and high ﬂuc activity were selected for further use. In
a second step, the conditional expression cassette, in which
the bidirectional tet-regulated promoter Ptet bi–1 (23)
controlled the expression of both miRNA3(FL-B) and
rluc gene, was randomly integrated into the genomes of
both HtTA 15 and 16. In the resulting triple transgenic
Tet-Off cell lines (Figure 2A), rluc activity mirrored the
kinetics of miRNA production from the tet-regulatable
promoter, whereas changes in ﬂuc activity reﬂected the
degree of miRNA-mediated RNAi.
From a total of 29 triple stable clones, three clones were
selected (Table 1), in which rluc activity can be regulated
in the range of more than three orders of magnitude by
doxycycline (dox). Interestingly, this resulted only in an
11-fold reduction of ﬂuc production at most. In the clone
HtTA 16-1, the knockdown efﬁciency of miRNA3(FL-B)
determined by either ﬂuc activity (Table 1) or ﬂuc mRNA
concentration (Supplementary Table S2) is highly compar-
able. Figure 2B shows the dose–response curve of
HtTA 16-1. As deduced from the curve, the expression
of miRNA3(FL-B) had to reach  13% of the induc-
tion maximum, achieved with dox concentrations of
 0.5ng/ml, to elicit RNAi.
These data favoured the conclusion that miRNA3
(FL-B) expression was rate limiting for the knockdown
of ﬂuc activity. However, the efﬁciency of ﬁnal steady
state gene inactivation in three analysed clones (residual
ﬂuc activity: HtTA 15-1: 14%; HtTA 16-1: 9%; HtTA
16-2: 12%;) seemed to be largely independent of the
maximal induction of miRNA3(FL-B), measured by rluc
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as much miRNA3(FL-B) in comparison to the other cell
clones, only results in a knockdown efﬁciency that is min-
imally higher. To address this discrepancy in more detail,
further experiments were performed.
Knockdown efﬁciency is largely independent from the
degree of target gene expression
Next, we tested whether the knockdown efﬁciency of
miRNA3(FL-B) was dependent on the initial concentra-
tion of the target mRNA. Therefore, we performed a
co-transfection experiment, in which miRNA3(FL-B)
interfered with the expression of a ﬂuc gene that was ex-
pressed either by PCMV or by the promoter of elongation
factor 1a (PEF1a). Fluc activities obtained in control trans-
fections (Table 2) demonstrated that expression from
PEF1a was  30 times lower than expression driven by
PCMV. Surprisingly, the resulting relative knockdown
efﬁciencies generated by Ptet–1 produced miRNA3(FL-B)
were identical in regard to the experimental error (residual
ﬂuc activity: CMV: 12%; EF1a: 8%). This possibly
indicates that a subpopulation of target gene mRNAs
escapes miRNA-mediated degradation independent of
the primary concentration of the targeted mRNA.
Figure 2. Dose–response analysis of tet-regulated miRNA3-mediated inactivation of ﬁreﬂy luciferase in the Tet-Off cell line HtTA 16-1.
(A) Schematic representation of sequence elements within the transgenic constructs used for the generation of triple stable HeLa cell lines. PCMV,
CMV-Promoter; tTA, tet-dependent transactivator; Ptet bi–1, bidirectional tet-regulated promoter; ﬂuc*, ﬁreﬂy luciferase fusion protein; rluc, renilla
luciferase; (A)n1, SV40 polyadenylation signal; (A)n2, b-globin polyadenylation signal. (B) Dose–response analysis of miRNA target gene ﬁreﬂy
luciferase (ﬂuc) and renilla luciferase (rluc) activity, mirroring miRNA transcription at various doxycycline (dox) concentrations in cell line HtTA
16-1, measured 72h after induction with dox and normalized to total protein concentration. Figure B shows means and SEM from multiple samples
of at least two independent experiments.
Table 1. Knockdown efﬁciency of tet-regulated miRNA3(FL-B) in stable cell lines
Cell line cDNA expression miRNA-mediated knockdown
Renilla luciferase activity (rlu/mg) Fireﬂy luciferase activity (rlu/mg)
–dox +dox fold regulation –dox +dox fold regulation
HtTA 15-1 53911±4291 54±19 1007 5104±536 35813±4166 7.0
HtTA 16-1 113063±6201 37±19 3087 6075±1129 68871±11679 11.2
HtTA 16-2 49210±14046 89±10 550 6585±502 55381±11521 8.4
Fluc and rluc luciferase activities, normalized to total protein concentration, obtained from cells of indicated triple stable HeLa Tet-Off lines, that
were grown in the absence (–dox) or presence (+dox) of 500ng/ml dox in the tissue culture medium for 72h.
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by tandem-arrayed miRNAs
About 40% of miRNA genes discovered so far are
organized in polycistronic clusters, from which they are
co-expressed by pol II as a single transcript (14,34).
From this primary transcript, pre-miRNAs are liberated
by RNase III cleavage activity of Drosha (15). Therefore,
arraying multiple rationally designed miRNAs offers the
possibility of either the simultaneous inactivation of
multiple genes or the targeting of a single gene by syner-
gistic action of multiple miRNAs targeting the mRNA at
different sequence sites.
To model the simultaneous inactivation of multiple
genes, miRNA3(RL-A) was cloned upstream of
miRNA3(FL-B) into the expression vector, in which the
miRNA3(FL-B) was already under Ptet–1 control. The
spacer sequence between the two miRNAs was 17nt for
tandem RL-A(17)FL-B and 54nt for tandem
RL-A(54)FL-B (Figure 3A). These two vectors were
then tested for their capability to knockdown both ﬂuc
and rluc in transient transfections. As shown in
Figure 3B, both tandem arrays of miRNAs reduced
activities of ﬂuc and rluc with the same efﬁciency as indi-
vidually expressed miRNAs. There was no difference
between the tandem RL-A(17)FL-B and the tandem
RL-A(54)FL-B, thus demonstrating that a spacing of
17nt is sufﬁcient for independent processing of both
miRNAs by Drosha. Cloning and testing of construct
tandem FL-B(17)RL-A, where miRNA3(RL-A) was
inserted downstream of miRNA3(FL-B) (Figure 3A),
revealed no positional advantage for miRNA within the
bicistron.
Given the option to target one transcript with two or
more different miRNAs, we next investigated whether the
simultaneous expression of miRNAs targeting the same
transcript at different target sites could further decrease
the residual activity upon knockdown achieved with only
a single miRNA. As seen in Figure 3C, individual
miRNAs targeting rluc mRNA at different sequences
(RL-A, RL-B, RL-C) reduced the production of rluc to
residual activities ranging from 11% to 23%. Next,
bicistronic DNA expression units expressed under
control of Ptet–1 were generated. Here, the ﬁrst cistron
consisted of one of the miRNA3 targeting rluc at RL-A
or RL-B or RL-C. The second cistron was always
miRNA3(RL-C). If the effect of the additional
miRNA3(RL-C) is linearly additive, the residual rluc
activity observed with one rluc targeting miRNA should
be lowered by additional 77% because of the expression of
miRNA3(RL-C). However, for miRNA3(RL-A) and
miRNA3(RL-B), no further reduction of residual rluc
activity was accomplished by the additional miRNA
(Figure 3C). In addition, the expression of a tandem
array of two miRNA3(RL-C) had only a minor effect
on further reducing residual activity compared to a
single cassette with only one miRNA.
Comparable residual activity after miRNA-mediated
knockdown is present in all affected cells
Furthermore, we addressed the nature of the residual gene
activity present after miRNA-mediated knockdown. We
asked whether it originated from a subpopulation of cells
deﬁcient for RNAi mediated knockdown or from a pool
of endogenous mRNAs that escaped the miRNA-
triggered degradation uniformly in most or all cells. As
a target we selected the TPX2 (targeting protein for
Xklp2) gene product, a protein recently identiﬁed to
play a key role in mitotic spindle formation in HeLa
cells (27,35). Suppression of TPX2 expression by transient
transfection of siRNAs led to a block of mitotic spindle
formation and subsequently to a persistent cell-cycle arrest
(27). Therefore, a subpopulation of cells deﬁcient in RNAi
machinery should be identiﬁable as dividing cells with
normal TPX2 expression.
To knockdown TPX2, we generated a stable cell line, in
which the expression of a miRNA3 targeting TPX2 and
the reporter gene eGFP was regulated by the Tet-On
system. Therefore, an expression cassette, in which the
bidirectional tet-dependent promoter controlled both the
expression of eGFP and miRNA3(TPX2-C), was
recombineered into the genome of a precursor cell line
HeLa EM2-11ht (25) by recombinase-mediated cassette
exchange, yielding cell line HeLa EM2-11-TPX2. To de-
termine the miRNA-mediated knockdown efﬁciency of
the endogenous TPX2, HeLa EM2-11-TPX2 cells were
cultured either in the absence or in the presence of dox,
harvested at different time points and analysed.
Expression of TPX2 protein could be reduced by
miRNA3(TPX2-C) to a residual level of below 10%
within 50h (Figure 4A). This reduction of TPX2 protein
concentration led to a dramatic reduction of spindle
microtubule density, as shown by the immunoﬂuorescence
staining of TPX2 and microtubules on a single cell level in
Figure 4C. Consistent with that and with previously pub-
lished results (27,35), knockdown of TPX2 caused an ac-
cumulation of cells in mitosis as visualized by indirect
immunoﬂuorescence using an antibody against the
mitosis-speciﬁc phosphorylation of histone H3 on serine
10 (Figure 4C, upper panels). Moreover, ﬂow cytometry
revealed a higher percentage of cells bearing G2/M DNA
content (4N) after TPX2 knockdown (Figure 4B, 15% in
controls without dox, as compared to 36% after addition
Table 2. Knockdown efﬁciency of miRNA3(FL-B) at different target
gene concentrations
Promoter Fireﬂy luciferase activity (rlu/mg)
Mock miRNA3(FL-B) fold regulation
CMV 32089±7964 4068±394 7.9
EF1a 1015±26 84±26 12.1
In transient expression experiments, either a vector expressing
miRNA3(FL-B) under the control of Ptet–1 [miRNA(FL-B)] or an
empty expression vector pUHD10-1 (mock) was co-transfected with a
plasmid constitutively producing a ﬁreﬂy luciferase protein, a plasmid
constitutively producing rluc and a vector constitutively expressing
tTA. In one case (CMV) the ﬂuc protein production was controlled
by the strong promoter PCMV, in the other case by the weaker promoter
of elongation factor 1 a PEF1a. From these transfection experiments,
ﬂuc activities were quantiﬁed and normalized to yielded rluc activities.
e168 Nucleic Acids Research, 2010,Vol.38, No. 17 PAGE 8 OF 17Figure 3. Simultaneous gene inactivation of multiple genes by tandem-arrayed miRNAs. (A) Schematic representation of sequences present in
expression vectors with tandem-arrayed miRNAs. Ptet–1, tet-regulatable promoter; (A)n1, SV40 polyadenylation signal. Brackets show the size of
the non-coding linker sequence separating the individual miRNAs of the type miRNA3. (B) Fireﬂy (ﬂuc) and renilla (rluc) luciferase activities were
quantiﬁed in a co-transfection experiment, in which the constitutive production of ﬁreﬂy and renilla luciferase from respective expression vectors was
inhibited by the indicated expression vector bearing a tet-regulated miRNA3 cassette. Measured luciferase activities were normalized to the present
ﬂuorescence intensity of eGFP, which was expressed under control of PCMV from an additional co-transfected expression plasmid. Structure of
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TPX2 could still be detected in miRNA3(TPX2-C) ex-
pressing cells. This was consistent with the analysis of
TPX2 knockdown efﬁciencies in a population of cells
using immunoﬂuorescence staining (Figure 4C, upper
panels): Variations in TPX2 protein concentrations were
observed in control cells (Figure 4C, TPX2, –dox) consist-
ent with changing protein concentration of TPX2 during
the cell cycle in human cells (27,36). In contrast, no cells
could be identiﬁed with a strong TPX2 signal upon expres-
sion of the TPX2-targeting miRNA (Figure 4C, TPX2,
+dox). To analyse this more quantitatively, we imaged
 200 cells from control and knockdown samples and
quantiﬁed the nuclear TPX2 signals by indirect immuno-
ﬂuorescence. While the average ﬂuorescence signal was
signiﬁcantly reduced upon expression of the
TPX2-targeting miRNA, the cells showed a similar
relative signal distribution. Most importantly, we did
not observe any cells with high TPX2 concentrations
upon miRNA expression (Figure 4D). This strongly
argues against the existence of a subpopulation of cells
still expressing original TPX2 protein concentrations in
the presence of the miRNA but favours the idea of a
homogenous gene knockdown, with homogenous
residual activity in all cells.
Supporting the evidence for the absence of any cells
showing normal, unmitigated expression of TPX2 in the
presence of miRNA3(TPX2-C), we tested the effect of
the miRNA-mediated TPX2 knockdown on tumour
growth of HeLa EM2-11-TPX2 in the nude mouse xeno-
graft model. Therefore, either 10
4 or 10
5 cells of line HeLa
EM2-11-TPX2 were injected subcutaneously along the
mammary line of nude mice. One group of mice (n=5)
never received dox treatment [and therefore did not
express miRNA3(TPX2-C)] and served as a control for
the tumourigenic properties of the cell line. The effect of
the miRNA3(TPX2-C) mediated suppression of TPX2 ex-
pression on tumour growth was studied in a second group
of mice (n=5), in which expression of miRNA3(TPX2-C)
in the inoculated cells was activated from day 7p.i.
onwards by treating the mice with dox in drinking water
(2mg/ml). To exclude any therapeutic effect of dox on
tumour growth itself, a third group of mice had received
corresponding quantities of cells of line HeLa
EM2-11-mCherry, in which the production of ﬂuc and
the red ﬂuorescent protein mCherry is controlled via the
Tet-On system (Kai Scho ¨ nig and Dusan Bartsch,
unpublished). These mice were treated with dox in
drinking water the same way as the animals of the
second group. Figure 4E shows tumour growth in all
three groups of mice within a period of 30day. Upon in-
oculation of 10
4 cells, switched off HeLa EM2-11-TPX2
as well as switched on HeLa EM2-11-mCherry cells
developed into measurable tumours. No tumours
appeared in mice from cells of line HeLa EM2-11-TPX2,
where tet-regulated expression of miRNA3(TPX2-C) had
been activated through dox treatment. If a subpopulation
of  10% RNAi defective cells were present in line HeLa
EM2-11-TPX2, injection of 10
5 cells should yield tumours
in similar size to those observed with 10
4 switched off cells
of the respective line (indicated by the red dotted line).
While injection of either 10
5 switched off HeLa
EM2-11-TPX2 cells or 10
5 switched on HeLa
EM2-11-mCherry cells gave rise to larger tumours
compared to injected 10
4 cells, still no tumours developed
from 10
5 cells with tet-activated miRNA3(TPX2-C) ex-
pression. This ﬁnding further supports the view that
there are no RNAi resistant cells in the injected
population.
Kinetic properties of tet-mediated gene inactivation
by miRNA3
A very important parameter of any conditional gene in-
activation strategy is the knowledge of the on- and off
kinetics of the respective system. Therefore, the onset
and the decay of miRNA-mediated RNAi was
investigated using the Tet-Off cell line HtTA 16-1.
Figure 5 shows the time course of the appearance of
miRNA-mediated gene inactivation in relation to the
onset of tet-regulated gene expression and mature
miRNA generation. As seen from rluc activity
(Figure 5A) and mRNA concentration (Figure 5B),
tet-regulated expression has a very fast onset, reaching
almost its maximal activity within the ﬁrst 24h after the
Tet-Off system has been activated by removal of dox. The
generation of mature miRNAs initiates more slowly and
stabilizes reaching a plateau 72h after miRNA expression
has been started (Figure 5C). The appearance of mature
miRNAs occurs in parallel with the decay of the targeted
gene, deduced from the exponential decay curves of ﬂuc
activity (Figure 5D) and mRNA concentration (Figure
5E), that show a half-life time of  15h in both cases.
Interestingly, exponential decay of target gene mRNA
initiated after a delay period of 10h.
Multiple studies have shown the capability of siRNAs
to induce epigenetic silencing through the assembly of het-
erochromatin in mammalian cells (37,38). To clarify
whether an extended time of expression of an RNAi-
capable miRNA has any long lasting, miRNA-
independent effect on the expression of the target gene
after expression of the interfering RNA has ceased, we
analysed the restoration of target gene expression after
various times of persistent miRNA production.
Therefore, miRNA3(FL-B) expression was induced in
HtTA 16-1 cells for 1, 2 or 4weeks. Subsequently
tandem expression vectors is described in (A) FL-B: expression vector with miRNA3(FL-B) under control of Ptet–1. RL-A, expression vector with
miRNA3(RL-A) under control of Ptet–1; FL-B + RL-A, co-transfection of two expression vectors containing either miRNA3(FL-B) or
miRNA3(RL-A) under control of Ptet–1.( C) Rluc activities were determined in a co-transfection experiment, in which the constitutive production
of renilla luciferase was inhibited by the indicated vectors and normalized to ﬂuc activity. RL-A, RL-B, RL-C: expression vectors with a single
miRNA3 targeting rluc at a particular sequence (A or B or C) under control of Ptet–1. Tandem bicistronic constructs follow the nomenclature as
described in (A). RL-A+ RL-C: co-transfection of two expression vectors containing either a single miRNA3(RL-A) or a single miRNA3(RL-C)
under the control of Ptet–1. Figures B and C show means and SEM from multiple samples taken from at least two independent transfection
experiments.
e168 Nucleic Acids Research, 2010,Vol.38, No. 17 PAGE 10 OF 17Figure 4. Tet-regulated gene knockdown of endogenous mitotic spindle assembly factor TPX-2 in Tet-On cell line HeLa EM2-11-TPX2.
(A) Immunoblot analysis of TPX2 concentrations in controls or 5, 25 and 50h after induction of tet-regulated expression of miRNA3 targeting
TPX2 by dox. TPX2 concentrations were normalized to present b-actin. (B) Flow cytometry analysis of cells grown for 44h in the absence (–dox) or
presence (+dox) of tet-induced expression of miRNA targeting TPX2. The y axis shows the number of cells stained by propidium iodide. The x axis
indicates the intensity of the cellular staining and thus the DNA content. 2N: diploid, 4N: tetraploid. The relative percentage of cells in either the G1
or G2/M cell-cycle stage is indicated above the peaks. (C) Immunoﬂuorescence analysis of cells as in (B). Cells expressing miRNA3(TPX2) (+dox) or
uninduced controls (–dox) were stained with either DAPI (DNA, blue in merge), an antibody against TPX2 (TPX2, red in merge), an antibody
PAGE 11 OF 17 Nucleic Acids Research, 2010,Vol.38, No. 17 e168against phosphoserine 10 in histone H3 (Histone H3, upper panel, green in merge), or an antibody against a-Tubulin (Tubulin, lower panel, green in
merge). Scale bars: 100mm (upper panels) and 10mm (lower panels). (D) A total of 200 cells from both control samples (–dox) and after TPX2
knockdown (+dox) were labelled using TPX2 antibodies. The intensity of each individual nuclear TPX2 signal was quantiﬁed and plotted as a dot.
(E) Tumour growth analysis of cell line HeLa EM2-11-TPX2 in the nude mouse xenograft model. 10
4 (points) or 10
5 cells (squares) of cell line HeLa
EM2-11-TPX2 (TPX2) or HeLa EM2-11 (Control) were injected subcutaneously along the right or left mammary line of CD1 nude mice. The
volume of developing tumours was monitored in vivo using an external caliper over a period of 30 days. One group of mice (+dox) was treated with
2mg/ml dox in drinking water starting from Day 7 after inoculation of cells. The other group (–dox) never received dox treatment. Black lines:
Average tumour volume (n=5) of control cell line in the presence of dox. Gray lines: Average tumour volume (n=5) of line HeLa EM2-11-TPX2
in the absence of dox. Purple lines: in the presence of dox. The dotted red line displays the tumour growth curve of 10
4 cells of line HeLa
EM2-11-TPX2 in the absence of dox.
Figure 5. Activation kinetic of tet-regulated miRNA3-mediated gene knockdown in Tet-Off cell line HtTA 16-1. Tet-regulated expression of
miRNA3(FL-B) and rluc was started in cell line HtTA16-1 (utilizing the Tet Off system) by removal of dox from the culture medium.
Activation of tet-regulated transcription of miRNA3(FL-B) and miRNA-mediated knockdown of ﬂuc was monitored over a period of 130h by
quantifying rluc (A) and ﬂuc (D) activity, relative rluc (B) and ﬂuc (E) mRNA concentration and the concentration of mature miRNA (C) in the
samples of HtTA 16-1 cells collected at the indicated time points. Both luciferase activities were normalized to total protein concentration, mRNA
and miRNA concentrations to the concentration of b-actin mRNA. Figures show means with SEM of multiple samples from two independent
experiments.
e168 Nucleic Acids Research, 2010,Vol.38, No. 17 PAGE 12 OF 17Figure 6. Recovery kinetics of target gene expression after the termination of the tet-regulated miRNA3-mediated gene knockdown in the Tet-Off
cell line HtTA 16-1. (A+D) Tet-regulated co-expression of miRNA3(FL-B) and rluc in the cell line HtTA16-1 (utilizing the Tet Off system) was kept
activated for 1week (red), 2 weeks (black) and 4weeks (green). Then, tet-regulated gene expression was switched off, by addition of dox (500ng/ml),
and rluc (A) and ﬂuc (D) activity measured at indicated time points over a period of 192h. Both luciferase activities were normalized to total protein
concentration. The boxed area marks the time period analysed in B, C and E. (B+C+E) Quantiﬁcation of relative rluc (B) and ﬂuc (E) mRNA
concentrations and the concentration of mature miRNA (C) within a period of 72h after tet-regulated gene expression, that has been activated for
2weeks, was switched off. The mRNA and miRNA concentrations were normalized to the concentration of b-actin mRNA In (E), 100% represents
the mRNA concentration in cells expressing no miRNA. Therefore, the rel. ﬂuc mRNA concentration mirrors the knockdown efﬁciency at respective
time points. Figures show means and SEM of multiple samples from two independent experiments. (F) Recovery of ﬂuc activity after
miRNA3(FL-B) knockdown in cell populations with different division rates. In cell line HtTA 16-1, miRNA expression was activated by
growing the cells in the absence of dox for 10days. After subsequent addition of dox to the tissue culture medium (500ng/ml) to terminate
tet-regulated miRNA3(FL-B) expression, cells were divided into two populations. In one population, the cell cycle was artiﬁcially elongated to
48h by the use of S-phase blocker thymidine (+thymidine, black). In the other population (–thymidine, white), cell division rate was left unaltered at
24h, serving as a control population. Figure shows ﬂuc activities (rlu/mg total protein) at Days 1, 5 and 9 normalized to a control experiment, in
which ﬂuc activities of the same time points were determined in both respective cell populations, that were never subjected to a miRNA-based
knockdown of ﬂuc expression.
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adding dox to the cell culture medium and the kinetics
of rluc decay (mirroring miRNA transcription) and the
ﬂuc reinduction were determined over extended times
(Figure 6A–E). After dox addition, the transcription
from the bidirectional tet-regulatable promoter ceased
very fast, independently of duration of activation, as
depicted by exponential decay curves for rluc activity
(Figure 6A) with an average half-life time of 5.2h. The
herein determined half-life of rluc activity is consistent
with previously reported values (39). Exponential decay
of rluc mRNA revealed a half-life time of 2.8h (Figure
6B). In contrast to this fast process, complete
reestablishment of basal ﬂuc activity was not achieved
until 5days after 1week (red line), and 7days after
2weeks (black line) or 4weeks (green line) of persistent
miRNA3 mediated knockdown (Figure 6D). However,
since comparable basal ﬂuc activities were reached after
all investigated times, an epigenetic modiﬁcation of
reporter gene expression is unlikely to have occurred.
Interestingly, computational analysis of sigmoidal
reinduction curves uncovered a doubling time of ﬂuc
activity recovery to be  24h. In addition, the concentra-
tion of mature miRNA decayed exponentially with a
half-life time of  20h in an experiment, where a sustained
production of the respective miRNA over 2weeks was
shut off (Figure 6C). Since HeLa cells divide every 24h,
these two observations indicated that the recovery of
targeted reporter gene expression to basal levels might
be simply due to the progressive dilution of
miRNA-activated RISCs by cell division.
To investigate this assumption in more detail, we con-
ducted an experiment, in which the doubling time of HtTA
16-1 was artiﬁcially extended to 48h by a
thymidine-mediated S-phase block. miRNA3(FL-B) ex-
pression was turned on for 10 days and as soon as
miRNA production was switched off, the respective cells
were split into two population, one control population,
and one with an elongated cell cycle of 48h. As seen in
Figure 6F, recovery of ﬂuc took much longer in cells
with an extended cell division time in comparison to cells
with an unaltered division rate. This provided further
evidence that a substantial component responsible for the
herein and previously observed (11,12) reinstatement of
basal target gene expression after miRNA-mediated
knockdown is cell division.
DISCUSSION
In the present study, we systematically characterized a
tet-regulated miRNA expression system, which is applic-
able for tissue speciﬁc, temporal down-regulation of any
gene of interest in mammalian cells and tissues. Our study
shows that the minimized miRNA design miRNA3 with
deﬁned miRNA core elements, when utilized in combin-
ation with a pol II promoter, promoted gene knockdowns
with a comparable efﬁciency to those achieved by the most
potent interfering RNA expressed from the pol III
promoter PH1. Pol II promoter driven expression of
RNAi-active transcripts has several beneﬁts, in particular
as a tool for a tissue speciﬁc, conditional gene inactivation
in transgenic animals. Not only can all the previously de-
veloped molecular components of the original tet system
be used, but also the large repertoire of already existing
characterized transactivator mouse lines (21) can be ex-
ploited. Previously described tet-regulatable pol III
systems (8,9) rely on a repression principle and are thus
unsuitable for reversible tissue-speciﬁc gene inactivation in
transgenic animals. The default state in these systems
is ubiquitous shRNA production and thus global inacti-
vation of the target gene in the entire animal, which can
only be suspended in those tissues, which express a
tet-sensitive transcriptional repressor or silencer. For the
establishment of a tissue-speciﬁc, tet-regulatable
knockdown an activator dependent, tet-regulated pol III
system developed recently (10) is a choice. Nevertheless,
several desired features like the simultaneous expression of
reporter genes together with the miRNA cannot be easily
realized with pol III based systems. Therefore, in our view,
the expression of miRNAs from pol II promoters is pref-
erable for studies of tissue-speciﬁc gene function in living
animals using RNAi knockdowns.
Although the use of tet-regulated miRNAs has been
described previously (11,12), our study now for the ﬁrst
time systematically analysed the critical sequence elements
necessary for efﬁcient gene knockdown. Through the com-
parison of different miRNA designs, we demonstrated
that sequences encoding for the cleavage site of the
Drosha nuclease and the nuclear export signal for
Exportin 5 are essential for the efﬁciency of a designer
miRNA, when expressed from a pol II promoter. The
general applicability of the proposed miRNA design was
further supported by demonstrating high knockdown
efﬁciency independent of the target sequence used and
the vector sequence in which the miRNA was integrated.
The designation of minimal essential sequences reduced
the total size of a highly effective miRNA to 106nt,
which requires a spacer of just 17nt to be functionally
recognized as an individual unit. The miRNA described
by Stegmeier and colleagues (12) worked only when
integrated into the 30-UTR of an open reading frame
possibly suggesting a deﬁciency in Drosha processing
and/or nuclear export could be compensated by an open
reading frame upstream of a miRNA.
Studying the regulatory properties of miRNA3 in a
quantitative way revealed three interesting aspects: ﬁrst,
the knockdown of gene expression via the miRNA was
not complete and the expression of the targeted gene per-
sisted above a certain threshold, independently of the
miRNA to target mRNA ratio. This enduring residual
activity of the targeted mRNA was neither affected by
increasing the miRNA concentration nor by lowering
the concentration of target mRNA. In addition, the in-
defatigable activity could not be eliminated by the simul-
taneous expression of second miRNAs targeting different
sequence sites within the transcript. In our TPX2
knockdown experiments, the residual activity was shown
to be homogenously distributed to all cells and did not
originate from a distinct, potentially RNAi-deﬁcient
subpopulation of cells. An RNAi-resistant gene activity
within the same range was also observed for synthetic
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siRNA experiments even higher residual activities
compared to our experiments were reported. But since
this residual activity is distributed to all cells, many bio-
logical experiments utilizing this system can be conducted,
as long as the endogenous inactivation of expression is not
compensated and sufﬁcient to elicit a phenotype. Here, we
were able to demonstrate the suitability of stable transgen-
ic cell lines utilizing this regulatory system to study the
biology of tumour formation.
Second, the use of quantiﬁable reporter genes expressed
from the bidirectional tet-regulated promoter in our study
allowed us to directly compare for the ﬁrst time the kinetic
features of the RNAi-mediated gene inactivation with in-
duction kinetics of the tet system itself. As expected,
miRNA-dependent mRNA degradation accompanies the
emergence of processed miRNAs and follows the rapid
induction of tet-regulated reporter gene expression with
a short delay. Interestingly, within the ﬁrst 10h after ini-
tiation of tet-regulated miRNA expression, we see a
decrease in target gene activity without a reduction of its
mRNA concentration. Both the activation of tet-regulated
gene expression (41) or the inducer doxycycline in doses
used (42) have no inhibitory effects on the cellular trans-
lation machinery. Therefore, we assume that within this
initial phase, inhibition of mRNA translation by
miRNA-loaded RISC complexes precedes mRNA degrad-
ation. In fact, it has been shown recently that a substantial
proportion of the RNAi-mediated gene down-regulation,
elicited by siRNAs or miRNAs fully complementary to
the respective target site, is mediated by translational re-
pression (43). Interestingly, these data support well our
assessment of the transient miRNA efﬁcacies. As seen in
Figure 1, knockdown efﬁciencies are higher when
calculated from reporter gene activities compared to
those deduced from mRNA concentrations. However, in
stable cell line HtTA16-1, 72h after activation of miRNA
expression, translational repression is not detectable and
knockdown efﬁciencies calculated from target gene
activities (Table 1) or mRNA concentrations
(Supplementary Table S2) are comparable. We suggest
that substantial translational repression by fully comple-
mentary miRNAs is present either within the initial phase
(10h) of the RNAi process, where all components neces-
sary for RISC-dependent mRNA degradation might not
be present or properly assembled, or for much longer
periods (3days) in transient transfection experiments, in
which a massive overexpression of the target gene is
commonly taking place. The results from transient experi-
ments also suggest that RISC-mediated mRNA degrad-
ation may be the time limiting step of RNAi process.
Third, we show that the assumption regarding the gen-
erally fast reversibility of a miRNA-mediated knockdown
(11,12) may be an overestimation. In contrast to the rela-
tively fast onset, reversal of induced miRNA-mediated
gene knockdown was observed here within only 6–8
days, consistent with other published data (11,12). Given
a 1-day doubling time of HeLa cells, the simplest explan-
ation for the observed half-life times of 24h for ﬂuc
activity recovery and of 20h for the decay of mature
miRNA concentration is the dilution of RNAi-active
complexes in several rounds of cell division, which drives
most of the process. This point of view is further sup-
ported by the fact, that the artiﬁcial elongation of HeLa
cell division to 48h slows down the recovery of target gene
expression mediated by previous miRNA expression.
Supposing that all detected mature miRNAs are part of
an active RISC complex, a mathematical correction of the
half-life time of mature miRNA concentration determined
herein for the cell division rate would yield a half-life time
for the pure decay of miRNA-loaded RISC complexes of
 140h. If this was the case, then a return to 95% of
original expression level of the targeted gene in
non-dividing cell types would take around 30 days.
Therefore, reversal of miRNA-mediated gene knockdown
within one cell cycle, as seen in the case of tet-regulated
gene expression, is unlikely. This interpretation is consist-
ent with recently published data, showing prolonged
duration of transient shRNA knockdown after cell-cycle
arrest (44). Although recent publications show reversibil-
ity of miRNA-mediated gene inactivation in transgenic
mice within a period of days, this was observed in highly
proliferative, oncogenic B-lymphocytes (45). For the
faithful assignment of half-life times of RNAi-active
RISCs and to address the question of general reversibility
of miRNA action in living animals, in our opinion quan-
titative data for gene knockdown in less proliferating cell
types are needed.
Despite the numerous potential beneﬁts of the RNAi
technology, its limitations have to be taken seriously.
We predict that residual activity of the target gene is an
intrinsic feature of miRNA knockdown and will therefore
remain a major limitation for the use of RNAi-mediated
gene inactivation, in particular where more substantive
down-regulation is necessary. In fact, the knockdown of
the enzyme mgcRACGAP to a residual 10–20% concen-
tration by a speciﬁc miRNA3 did not result in the
expected cellular phenotype (data not shown). The other
important issue is the expected slow reversibility of the
system in slowly dividing or non-dividing cells and the
risk that the competition between the exogenous
miRNA and the endogenous miRNAs for RISC forma-
tion would eventually be deleterious to the cellular metab-
olism, arising after an estimated intrinsic lag phase of
4weeks. In fact, strong overexpression of shRNAs in the
liver led to severe toxicity and high mortality rate in mice
only after a period of  4 weeks (46).
In conclusion, our data deﬁne the frame within which
conditional gene inactivation via tet-regulated miRNAs is
effective. The use of Ptet bi–1 allows the simultaneous ex-
pression of miRNAs with a reporter function for identify-
ing and quantitatively monitoring cells expressing the
miRNAs. Even though miRNA technology has its limita-
tions, this approach allows auspicious experimental
designs. For example, co-expression of two or more
miRNAs allows simultaneous targeting of multiple genes
at once. Such approaches will be fruitful for targeting
highly redundant regulatory pathways. Furthermore, a
cDNA encoding a mutant of a gene of interest can be
co-expressed with a miRNA targeting the endogenous un-
altered gene generating a conditional gene replacement. In
the absence of totipotent, germline competent embryonic
PAGE 15 OF 17 Nucleic Acids Research, 2010,Vol.38, No. 17 e168stem cells from organisms other than mice, the use of the
inducible gene knockdown system will enable targeted
gene inactivation in species, where pronuclear injection
is technically feasible. This includes not only the rat
model, the most widely used model in physiology and
neurobiology, but almost all commercially important
livestock.
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